Financhill
Sell
29

LXEO Quote, Financials, Valuation and Earnings

Last price:
$2.71
Seasonality move :
-11.66%
Day range:
$2.53 - $2.86
52-week range:
$1.45 - $19.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.76x
Volume:
957.2K
Avg. volume:
1.1M
1-year change:
-80.74%
Market cap:
$89.3M
Revenue:
--
EPS (TTM):
-$3.08

Earnings Data

Next earnings date for LXEO
May 16
2025
Most recent earnings per share
-$0.78
Missed by $0.00
(Mar 24/2025)
Consensus Estimate
-$0.78
(Mar 24/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LXEO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/12/2025 Q2 -- -- -- -$0.75 --
05/16/2025 Q1 -- -- -- -$0.77 --
03/24/2025 Q4 -- -- -$0.78 -$0.78 -$0.00
11/13/2024 Q3 -- -- -$0.89 -$0.67 -$0.22
08/12/2024 Q2 -- -- -$0.64 -$0.69 $0.05
05/09/2024 Q1 -- -- -$0.77 -$0.79 $0.02
03/11/2024 Q4 -- -- -$0.53 -$0.75 $0.22
12/11/2023 Q3 -- -- -$0.80 -$3.02 $2.22
06/30/2023 Q2 -- -- -$0.53 -- --
03/31/2023 Q1 -- -- -$0.74 -- --
12/31/2022 Q4 -- -- -$0.58 -- --
09/30/2022 Q3 -- -- -$0.68 -- --
06/30/2022 Q2 -- -- -$0.60 -- --

Lexeo Therapeutics Earnings Questions

  • How Much did Lexeo Therapeutics Generate in Revenue Last Quarter?

    Lexeo Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Lexeo Therapeutics Beat Earnings Last Quarter?

    Lexeo Therapeutics announced earnings per share of -$0.78 which represents a miss of analyst forecast a -$0.78 per share.

  • Is Lexeo Therapeutics Profitable?

    Lexeo Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Lexeo Therapeutics EPS Next Year?

    Lexeo Therapeutics's earnings are forecast to decrease from -$3.09 per share to -$3.09 per share next year representing a decrease of -0.07%.

  • When is Lexeo Therapeutics's Earnings Date?

    Lexeo Therapeutics's next earnings date is May 16, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Is Acuity a Good Stock to Buy Now?
Is Acuity a Good Stock to Buy Now?

Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
74
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
71
NUTX alert for May 15

Nutex Health [NUTX] is up 9.76% over the past day.

Buy
81
EXEL alert for May 15

Exelixis [EXEL] is up 3.67% over the past day.

Sell
29
GLBE alert for May 15

Global E Online [GLBE] is down 3.44% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock